Atopic Dermatitis
Eye on OX40: U.S. FDA Clears IND Application for STAR-0310 in AD
December 11, 2024
Dupilumab Improves AD in Kids With and Without Type 2 Comorbidities
December 5, 2024
Linked: Air pollution and Eczema
November 13, 2024